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Background: Histoplasma capsulatum and Pneumocystis organisms cause host infections primarily affecting the
lung tissue. H. capsulatum is endemic in the United States of America and Latin American countries. In special
environments, H. capsulatum is commonly associated with bat and bird droppings. Pneumocystis-host specificity has
been primarily studied in laboratory animals, and its ability to be harboured by wild animals remains as an important
issue for understanding the spread of this pathogen in nature. Bats infected with H. capsulatum or Pneumocystis spp.
have been found, with this mammal serving as a probable reservoir and disperser; however, the co-infection of
bats with both of these microorganisms has never been explored. To evaluate the impact of H. capsulatum and
Pneumocystis spp. infections in this flying mammal, 21 bat lungs from Argentina (AR), 13 from French Guyana (FG), and
88 from Mexico (MX) were screened using nested-PCR of the fragments, employing the Hcp100 locus for H. capsulatum
and the mtLSUrRNA and mtSSUrRNA loci for Pneumocystis organisms.
Results: Of the 122 bats studied, 98 revealed H. capsulatum infections in which 55 of these bats exhibited this infection
alone. In addition, 51 bats revealed Pneumocystis spp. infection of which eight bats exhibited a Pneumocystis infection
alone. A total of 43 bats (eight from AR, one from FG, and 34 from MX) were found co-infected with both fungi,
representing a co-infection rate of 35.2% (95% CI = 26.8-43.6%).
Conclusion: The data highlights the H. capsulatum and Pneumocystis spp.co-infection in bat population’s
suggesting interplay with this wild host.
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Histoplasmosis due to Histoplasma capsulatum and
pneumonia caused by Pneumocystis spp. are fungal dis-
eases that can generate serious and even life-threatening
pneumonia in immunosuppressed hosts. H. capsulatum is
a fungal pathogen that affects a wide range of mammal
species, including the human. Autochthonous clinical cases
have been reported between the latitudes 54° 05′ North
(Alberta, Canada) and 38° South (Neuquén, Argentina)
[1,2]. The disease associated with this fungus is relevant in* Correspondence: emello@unam.mx
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distribution, and reproduction in any mediumthe geographical areas where histoplasmosis is endemic
or epidemic, such as the Missouri, Ohio, and Mississippi
river valleys, in the United States of America (USA), and
some Latin American countries with a high frequency
of outbreaks [3,4]. In Mexico, histoplasmosis is widely
distributed and case reports are rather variable [4]. In-
fection is caused by the inhalation of fungal saprobe
mycelial-phase propagules (infective form) that develop
in special environments and are mainly found in bat
guano accumulated in confined spaces such as caves
and abandoned mines and buildings. The potential role
of bats in spreading H. capsulatum in nature remains
unclear. The high risk of natural bat infection with this
fungus in Mexican caves has been well-documented [5-8].ed Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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lates from different geographical origins have been grouped
into eight clades; seven of which are considered phylogen-
etic species. Among these, highlight the LAm A clade that
harbours significant genetic variability [9].
The genus Pneumocystis contains highly diversified
fungal pathogens that are harboured by a wide range of
mammal hosts [10-16]. Pneumocystis organisms, which
are transmitted via host-to-host airborne route, have a
marked host-species-related diversity that is associated
with close host specificity. The high divergence among
Pneumocystis species most likely resulted from a pro-
longed process of co-evolution with each mammal host,
mostly associated with co-speciation, as suggested by
Demanche et al. [12] and Hugot et al. [13]. Although most
phenotypic and genotypic data supporting Pneumocystis
stenoxenism derives from laboratory animal models
or captive animals, reports about Pneumocystis prevalence
and circulation in wild fauna are scarce [12-16].
Unpublished preliminary data by our team revealed
H. capsulatum and Pneumocystis co-infection in two ran-
domly captured bats, identifying these mammals as prob-
able reservoirs and dispersers of both parasites in nature
(Dei-Cas E and Taylor ML, comm. pers.). The study of co-
infection systems, where the host (i.e. a wild host) usually
harbours two or multiple parasites, requires an in-depth
investigation to determine a comprehensive understanding
of this multi-infectious process in regards to its dynamics
and consequences.
H. capsulatum and Pneumocystis share a number of
features that justify their concomitant study, including: a
low pathogenicity in healthy hosts and severe disease
in immunocompromised hosts; an induced immune
response; a respiratory portal of entry; and the ability to
disseminate from the lungs to other organs. Therefore, it
is possible that co-infection between both parasites is
highly common in nature.
The aim of the present research was to detect the
frequency of the H. capsulatum and Pneumocystis or-
ganisms’ infection and co-infection in the lung samples
of a number of wild bat species from three countries
from Latin America. For this purpose, we used a highly
sensitive PCR with specific molecular markers for each




A total of 122 bats from different species and families
were randomly captured as reported by Taylor et al. [7]:
21 came from Argentina; 13 came from French Guyana;
and 88 came from Mexico. In all cases national rules
regulating bat species protection, capture, and process-
ing have adhered to strict ethical recommendations andto the guidelines published by Gannon, Sikes and the
Animal Care and Use Committee of the American Society
of Mammalogists [17].
The bats were euthanized by cervical dislocation and
processed according to recommendations and approval
of the Faculty of Medicine Ethics Committee, in accord-
ance with the Animal Care and Use Committee of the
UNAM and the Mexican Official Guide (NOM 062-
ZOO-1999). The lungs from each bat captured in Mexico
were separated and immediately frozen at −20°C. Animals
captured in Argentina and French Guyana were also eutha-
nized by cervical dislocation and processed in situ and
their lungs were separated and preserved in 70% ethanol
until DNA extraction.
DNA samples
DNA was extracted from the bat lungs using a DNeasy
Blood & Tissue Kit (Qiagen, Valencia, CA, USA). After
extraction, the DNA samples were frozen at −20°C. The
DNA samples were screened for H. capsulatum infection
using nested-PCR for a fragment of the gene encoding a
100-kDa protein (Hcp100) [18], a molecular marker con-
sidered to be highly specific for this pathogen. Molecular
screening for Pneumocystis spp. infection was conducted
in parallel, using nested-PCR for fragments of the rRNA
mitochondrial large [19,20] and small [21] subunit loci,
mtLSUrRNA and mtSSUrRNA, respectively.
Nested PCR assay of the Hcp100 locus for the detection of
H. capsulatum
The assay was performed as described by Bialek et al.
[18] with minor modifications by Taylor et al. [22] that
did not change the specificity and sensitivity of the
Hcp100 marker. Two sets of primers, described by Bialek
et al. [18], were used: the outer primer set included HcI
(5′-GCG-TTC-CGA-GCC-TTC-CAC-CTC-AAC-3′) and
HcII (5′-ATG-TCC-CAT-CGG-GCG-CCG-TGT-AGT-3′);
the inner primers were HcIII (5′-GAG-ATC-TAG-TCG-
CGG-CCA-GGT-TCA-3′) and HcIV (5′-AGG-AGA-
GAA-CTG-TAT-CGG-TGG-CTT-G-3′) and delimit a
210 base pair (bp) fragment unique to H. capsulatum.
The primers were supplied by Operon Technologies Inc.
(Alameda, CA, USA).
The first and second PCR reactions of the Hcp100
locus were standardised elsewhere [6]. For the first round
of amplification, the thermocycling conditions were as fol-
lows: one cycle at 94°C for 5 min; 35 cycles at 94°C for
30 s, 50°C for 30 s and 72°C for 1 min; and a final cycle at
72°C for 5 min. Thermocycling conditions for the second
PCR (nested reaction) were: one cycle at 94°C for 5 min;
30 cycles at 94°C for 30 s, 65°C for 30 s and 72°C for
1 min; and a final extension cycle at 72°C for 5 min. The
DNA (20 ng) of the EH-53 H. capsulatum strain from a
Mexican clinical case was used as a positive amplification
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control.
Nested PCR assays of the mtLSUrRNA and mtSSUrRNA loci
for the detection of Pneumocystis spp.
The assays were based on amplifying fragments of the
mitochondrial large (mtLSU) and small (mtSSU) sub-
units of the rRNA gene.
Nested PCR at the mtLSUrRNA locus employed
the outer primer set published by Wakefield et al.
[19], pAZ102-H (5′-GTG-TAC-GTT-GCA-AAG-TAG-
TC-3′) and pAZ102-E (5′-GAT-GGC-TGT-TTC-CAA-
GCC-CA-3′). The inner primers pAZ102-X (5′-GTG-
AAA-TAC-AAA-TCG-GAC-TAG-G-3′) and pAZ102-Y
(5′-TCA-CTT-AAT-ATT-AAT-TGG-GGA-GC-3′) and
delimit a 267 bp fragment for Pneumocystis [20]. The
first and nested PCR reactions of the mtLSUrRNA locus
were standardised as described elsewhere [14,19,20]. For
the first round of amplification, the thermocycling condi-
tions were as follows: 30 cycles at 94°C for 30 s, 50°C for
1 min, and 65°C for 1 min. The nested reaction was per-
formed with 10% of the first-round amplification product
and the thermocycling conditions were: 30 cycles at 94°C
for 30 s, 55°C for 1 min, and 65°C for 1 min.
Nested PCR at the mtSSUrRNA locus was per-
formed with the outer primers, pAZ112-10 F (5′-GGG-
AAT-TCT-AGA-CGG-TCA-CAG-AGA-TCA-G-3′) and
pAZ112-10R (5′-GGG-AAT-TCG-AAC-GAT-TAC-TAG-
CAA-CCC-3′). The inner primers pAZ112-13RI (5′-
GGG-AAT-TCG-AAG-CAT-GTT-GTT-TAA-TTC-G-3′)
and pAZ112-14RI (5′-GGG-AAT-TCT-TCA-AAG-AAT-
CGA-GTT-TCA-G-3′) and delimit a 300 bp fragment for
Pneumocystis species, as reported by Tsolaki et al. [21].
PCR for the mtSSUrRNA locus was previously described
by Tsolaki et al. [21] and Akbar et al. [14]. For the first
round of amplification, the thermocycling conditions were
as follows: 40 cycles at 94°C for 30 s, 55°C for 1 min, and
65°C for 1 min. The nested round was performed with 10%
of the first-round amplification product and the thermocy-
cling conditions were: 10 cycles at 94°C for 30 s, 52°C for
1 min, and 65°C for 1 min, followed by 30 cycles at 94°C
for 30 s, 63°C for 1 min, and 65°C for 1 min.
Primers for the mtLSUrRNA and mtSSUrRNA loci were
supplied by Operon Technologies. The DNA (20 ng) of
rabbit Pneumocystis (Pneumocystis oryctolagi) was proc-
essed as a positive amplification control, and Milli-Q water
was used as a negative control for both Pneumocystis
molecular markers.
Amplified products
Amplicons from each PCR assay were electrophoresed
through 1.5% agarose in 0.5X Tris-borate-EDTA buffer.
Electrophoresis was conducted at 120 V for 50 min. The
100 bp DNA Ladder (Gibco Laboratories, Grand Island,NY, USA) was used as a molecular size marker. The
bands were visualised using a UV transilluminator after
ethidium bromide staining (0.5 μg/mL). The amplicons
were purified using the QIAquick® PCR and the QIAEX
II kits (Qiagen) for the H. capsulatum and Pneumocystis
organisms, respectively. Afterwards, the amplicons were
sent to the Molecular Biology Laboratory, Institute of
Cellular Physiology (UNAM, Mexico) for sequencing in
an ABI-automated DNA sequencer (Applied Biosystems
Inc., Foster City, CA, USA). Sequencing reactions were
performed for forward and reverse DNA strands, and a
consensus sequence for each amplified bat lung sample
product was generated. The sequences were edited and
aligned using the MEGA software, version 5 (http://www.
megasoftware.net).
Most of the Hcp100 sequences of H. capsulatum
were previously reported in González-González et al.
[6], and the other sequences were deposited in a data-
base [GenBank: from JX091346 to JX091370 accession
numbers]. All sequences generated by both molecular
markers for Pneumocystis spp. were reported by Derouiche
et al. [16] and Akbar et al. [14].
The sequences of the specific markers for each patho-
gen (i.e., Hcp100 for H. capsulatum and mtLSUrRNA or
mtSSUrRNA for Pneumocystis spp.) that were obtained
in the same animal were the main inclusion criterion for
considering bat co-infection.
Statistics
The infection and co-infection rates for each pathogen
were estimated by considering all of the bats studied
from the three countries and from each country separ-
ately (Argentina, French Guyana, and Mexico), in rela-
tion to those bats with H. capsulatum and Pneumocystis
spp. infections as identified by sequencing their respective
molecular markers. The corresponding 95% confidence
interval (CI) was calculated using a normal distribution.
Results
Data from nine bat species studied belonging to five differ-
ent families, highlighting their particular behaviours, such
as migration, nourishment, distribution in the American
continent and colony size, are referred to in Table 1,
according to Ceballos and Oliva [23]. These behaviours
varied considerably among the bat species studied (Table 1).
The different species captured, their numbers, and their
geographical origins are registered in Table 2. Although
most of the bat species studied were non-migratory, the
number of migratory bats from three processed species
was greater than that of the non-migratory species (Tables 1
and 2). It is noteworthy that among the 122 bats studied,
84 (68.80%) belonged to the migratory species Tadarida
brasiliensis, from which 63 individuals were captured in
Mexico and 21 in Argentina (Table 2).
Table 1 Families, species, and behaviours of the bats studied
(Family) Species Migration Nourishment Distribution Colony size
(Phyllostomidae)
Artibeus hirsutus Non-migratory Frugivorous From south of Sonora to south of
Guerrero, Mexico
Not defined
Carollia perspicillata Non-migratory Frugivorous From Tamaulipas to Oaxaca, Mexico,
and to south of Bolivia, Brazil and
Paraguay
Small groups from 10 to 100
individuals
Glossophaga soricina Non-migratory Nectarivorous, polinivorous,
frugivorous and insectivorous
From Mexico to South America From a few to 2,000 individuals
(Natalidae)
Natalus stramineus Non-migratory Insectivorous From north of Mexico to Brazil Approximately 10,000 individuals
(Mormoopidae)
Pteronotus davyi Non-migratory Insectivorous From north of Mexico to Brazil From hundreds to thousands
of individuals
Pteronotus parnellii Non-migratory Insectivorous From north of Mexico to Brazil From hundreds to thousands
of individuals
Pteronotus parnellii Non-migratory Insectivorous From north of Mexico to the north
of Argentina and Paraguay
Thousands of individuals
Mormoops megalophylla Migratory Insectivorous From south USA to Venezuela
and Peru
From a few to thousands of
individuals
(Molossidae)
Tadarida brasiliensis Migratory Insectivorous From central USA to Chile and
Argentina





Insectivorous From western Canada and USA to
Guatemala
Small groups or gregarious
Data from the bat species were reported by Ceballos and Oliva [23].
Table 2 Species, numbers, and geographical origins of the bats infected with H. capsulatum or Pneumocystis spp.
Species Geographical origins/
localities
Number of bats infected with H. capsulatum/
Pneumocystis
Argentina French Guyana Mexico (Total samples
per species)
TUC CBA Kourou CS MN GR HG MS NL
H. capsulatum/Pneumocystis (total samples)
A. hirsutus 5/3 (5) 5/3 (5)
C. perspicillata 1/0 (1) 1/0 (1)
G. soricina 3/6 (12) 4/3 (4) 7/9 (16)
N. stramineus 5/1 (8) 5/1 (8)
P. davyi 1/0 (1) 1/0 (1)
P. parnellii 2/0 (2) 0/1 (1) 2/1 (3)
M. megalophylla 2/0 (2) 1/0 (1) 3/0 (3)
T. brasiliensis 16/8 (16) 3/ND (5) 8/2 (8) 7/2 (8) 13/5 (20) 26/19 (27) 73/36 (84)
M. californicus 1/1 (1) 1/1 (1)
Number of bats infected with
H. capsulatum/Pneumocystis
(Total samples per locality)
16/8 (16) 3/ND (5) 4/6 (13) 8/2 (8) 7/2 (8) 14/4 (17) 13/6 (21) 5/3 (5) 28/20 (29) 98/51 (122)
Abbreviations: TUC = Tucumán; CBA = Córdoba; CS = Chiapas; MN =Michoacán; GR = Guerrero; HG = Hidalgo; MS =Morelos; NL = Nuevo León.
ND = Not determined.
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samples
Of the 122 bat lungs that were molecularly screened for
H. capsulatum infection, 98 bats generated sequences
for the Hcp100 marker, of which 55 bats were found to
be infected with this pathogen alone, corresponding to
45.1% (95% CI = 36.4-53.6%) of the 122 bats from the
three geographical regions studied (Figure 1).
Table 2 displays the number of infected bats with
H. capsulatum in relation to the total number of each bat
species sampled at different localities from the monitored
Latin American countries.
Detection of Pneumocystis spp. infection in the bat lung
samples
Of the 122 lungs that were molecularly screened for
Pneumocystis spp., 51 bats generated sequences for one
or both of the Pneumocystis molecular markers assayed.
From these sequences, seven matched the mtLSUrRNA
locus and another seven matched the mtSSUrRNA locus,
while 37 sequences were generated at both loci. Pneumo-
cystis spp. infection alone was found only in eight bats,
corresponding to 6.6% (95% CI = 2.25-10.85%) of the
total bats studied (Figure 1).
Table 2 displays the number of infected bats with
Pneumocystis spp. in relation to the total number of each
bat species sampled at different localities from the moni-
tored Latin American countries.
H. capsulatum and Pneumocystis spp. co-infection in the
bat lung samples
Of the lung samples from the 122 bats captured in
Argentina, French Guyana, and Mexico that were mo-
lecularly screened for H. capsulatum and Pneumocystis
infections, 43 samples revealed the specific sequences ofFigure 1 Percentages of H. capsulatum and Pneumocystis infection an
Argentina, French Guyana, and Mexico. Each percentage value was calc
with specific molecular markers for each pathogen, as described in the Meeach pathogen, corresponding to 35.2% (95% CI = 26.8-
43.6%) of the samples being co-infected with both patho-
gens in bats from the three geographical regions studied
(Figure 1).
Table 3 displays the number of co-infected bats with
both pathogens in relation to the total number of each
bat species sampled at different localities from the moni-
tored Latin American countries.
Finally, of the total number of bat lungs sampled, 106
(86.8%, 95% CI = 80.92-92.68%) were found to be in-
fected with one or both pathogens, whereas 16 (13.1%,
95% CI = 7.22-18.98%) did not show evidence of infec-
tion with any of the pathogens studied (Figure 1).
Discussion
The co-infection relationship between the host and dif-
ferent parasite species could occur in natural conditions,
although it has been scarcely studied due to its complex-
ity and poor understanding [24]. The presence of more
than one parasite species in a single host can lead to
positive or negative interactions. In the positive inter-
action, the parasite could favour the entry and survival
of another parasite, whereas in the negative interaction
the establishment of a parasite prevents the entry of
other parasites and abolishes their survival [24]. It is well
accepted in medical research that the infection concept
implies the presence of the pathogen in the infected
host’s tissues, which does not necessarily indicate a dis-
ease status that is supported by characteristic signs and
symptoms. Although bats, in general, have a high infec-
tion rate with H. capsulatum in their shelters, they most
likely do not develop a severe course of the disease [7],
and the impact of this infection on the survival of their
population is unknown. With regard to Pneumocystis bat
infection, this wild host could present a latent infectiond their respective co-infection in bats randomly sampled in
ulated based on the 122 bats captured. Bat infection was screened
thods section.
Table 3 Species, numbers, and geographical origins of the bats co-infected with H. capsulatum and Pneumocystis spp.
Species Geographical origins/localities
Argentina (n = 21) French Guyana (n = 13) Mexico (n = 88) Number of co-infected bats
TUC CBA Kourou CS MN GR HG MS NL (Total samples per species)
Co-infection (total samples)
A. hirsutus 3 (5) 3 (5)
C. perspicillata 0 (1) 0 (1)
G. soricina 1 (12) 3 (4) 4 (16)
N. stramineus 1 (8) 1 (8)
P. davyi 0 (1) 0 (1)
P. parnellii 0 (2) 0 (1) 0 (3)
M. megalophylla 0 (2) 0 (1) 0 (3)
T. brasiliensis 8 (16) 0 (5) 2 (8) 2 (8) 3 (20) 19 (27) 34 (84)
M. californicus 1 (1) 1 (1)
Number of co-infected bats
(Total samples per locality)
8 (16) 0 (5) 1 (13) 2 (8) 2 (8) 4 (17) 3 (21) 3 (5) 20 (29) 43 (122)
Abbreviations: TUC = Tucumán; CBA = Córdoba; CS = Chiapas; MN =Michoacán; GR = Guerrero; HG = Hidalgo; MS =Morelos; NL = Nuevo León.
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[12,14]. Consequently, bats could be potential carriers of
both parasites in the environment.
H. capsulatum and Pneumocystis spp. cause a host
infection through the respiratory airway, mainly affecting
the pulmonary tissue. After infecting the lungs, each
parasite develops on distinct host environments and ex-
ploits different host resources. The H. capsulatum para-
sitic yeast-phase is an intracellular pathogen of the lung
phagocytic cells. In contrast, Pneumocystis organisms are
extracellular pathogens that frequently attach to type I
pneumocytes [10].
Histoplasma-Pneumocystis co-infection has been reported
in immunosuppressed human patients [25], whereas
reports of co-infection in wild mammals have not been
published. This fact should be re-examined because both
parasites are able to share the same wild hosts in a particu-
lar manner, likely associated with the host immune status
related to stress, sickness, and nutrient starvation.
PCR assays that utilize specific molecular markers are
very sensitive tools for detecting a low fungal burden in
clinical samples from asymptomatic patients. Currently,
H. capsulatum and Pneumocystis spp. infections are
detected by different PCR methods, either in human
clinical cases or in experimental models [14,26-29]. The
present study is the first report for detecting a natural
co-infection in wild bats from three distant geographical
Latin American regions, using specific PCR assay for
each parasite.
The numbers of wild bats infected with H. capsulatum
or Pneumocystis organisms varied, with the number
of H. capsulatum infected bats surpassing the number
of Pneumocystis infected bats (Figure 1). No association
was found between a bat species’ susceptibility andnourishment and the rate of infection with both patho-
gens. However, it is possible that some bat behaviours pro-
mote different infection rates for either H. capsulatum or
Pneumocystis spp. According to published findings, the
rates of each pathogen infection could be associated with
the bat colony size and their movements, in the case
of H. capsulatum [7], or with behavioural factors such as
bats crowding and migration in the case of Pneumocystis
spp. [14]. The biggest colonies, mainly of T. brasiliensis,
had the highest rate of infection with H. capsulatum, most
likely due to bat colony movements within enclosed
spaces, especially in shelters where short ceiling-to-floor
distances prevails, which facilitate the development of a
great number of airborne infective propagules on the abun-
dant guano accumulated underneath bat colonies [7].
Hence, each of these factors allows the co-infection state
with both pathogens.
Based on the following evidence, it is likely that either
H. capsulatum or Pneumocystis displayed an interaction
with different bat species since million of years ago (Ma):
1.- Bat fossils (Tadarida sp.) were reported approximately
3.6 – 1.8 Ma in the Late Pliocene [30]; 2.- the H. capsula-
tum complex most likely started its radiation at 13–3 Ma
in the Miocene [9]; and 3.- the Pneumocystis species have
had interaction with mammal hosts for more than 100 Ma
[10-13,31]. Under this assumption, the co-infection of both
pathogens most likely generated a co-evolution process
between each pathogen and the wild host.
Data pertaining to Histoplasma-Pneumocystis co-
infection reveal a rate of 35.2%; this finding could be use-
ful for understanding the persistence of both infections
in susceptible hosts. The absence of Histoplasma or
Pneumocystis infections in 13.1% of the bats studied
could suggest that most of the analysed bat populations
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gens in their shelters. Co-infection interactions could
cause ecological and immunological implications for the
host. For the ecological implications, space and alimen-
tary competitions are involved. For the immunological
implications, the host immune response against H. cap-
sulatum at the pulmonary level involves cells and mole-
cules that could also participate in the host immune
response against Pneumocystis, or vice versa.
Conclusion
The impact of the present findings highlights the H. cap-
sulatum and Pneumocystis spp. co-infection in bat popu-
lation’s suggesting interplay with this wild host. In
addition, this co-infection state could also interfere with
the outcome of the disease associated with each pathogen.
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